Telomir Pharmaceuticals Inc. (TELO) Live Share Price, Invest From India

Telomir Pharmaceuticals Inc. Stock Performance

as on June 27, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.21
Day's Price Range
$1.27
$1.24
2.42%
Downside
2.42%
Upside
52 Week's Low
52 Week's High
$1.05
52-Week Price Range
$3.10
$1.24
15.32%
Downside
150.00%
Upside

Telomir Pharmaceuticals Inc. share price movements today

Previous Close: $1.23
Open: $1.22
Volume: 175.9K
Day's Low - High: $1.21 - $1.27
52 Week Low - High: $1.05 - $3.10

Telomir Pharmaceuticals Inc. Historical Returns

1 Month Return: -4.65 %
3 Month Return: -2.38 %
1 Year Return: -27.65 %
3 Year Return: 0 %
5 Year Return: 0 %

Telomir Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Telomir Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$84.6M

EPS (TTM)

-0.38

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-384.26%

Telomir Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Telomir Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Telomir Pharmaceuticals Inc.	NA	$84.6M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Telomir Pharmaceuticals Inc. Stock including INR - Dollar returns

The Telomir Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Telomir Pharmaceuticals Inc. investment value today

Current value as on today

₹80,261

Returns

-₹19,739

(-19.74%)

Returns from Telomir Pharmaceuticals Inc. Stock

-₹27,059 (-27.06%)

Dollar Impact

₹7,320 (+7.32%)

Indian Investors' Interest in Telomir Pharmaceuticals Inc. Stock

Search interest for Telomir Pharmaceuticals Inc. Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 30, 2026 to June 29, 2026

Change:7% versus previous 30 day period

Telomir Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	18	-	-	-	-	-
Gross Profit	-	-1	-1	-6	9	-	-	-	-	-
Operating Income	-1	-1	-1	-6	-2	-2	-5	-1	-2	-1
EBITDA	-8	-1	-1	-5	-2	-2	-5	-1	-2	0
Interest Expense	0	4	-	-	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-9	-6	-1	-5	-2	-2	-5	-1	-2	0
Income Tax Expense	-1	-1	-	-	-	-	-	-	-	-
Net Income	-9	-6	-1	-5	-2	-2	-5	-1	-2	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-15.42%	0.00%	0.00%	0.00%	0.00%	0.00%

Telomir Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Sep 2021	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-3	-	-
Operating Income	0	0	-3	-12	-10
EBITDA	0	0	-11	0	-10
Interest Expense	-	-	1	4	-
Depreciation	-	-	-	-	-
Income Before Tax	0	0	-13	-16	-10
Income Tax Expense	0	0	-2	-16	-
Net Income	0	0	-13	-16	-10
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Telomir Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-6	-1	-5	-2	-2	-5	-1	-2	0
Operating Cash Flow	-1	-1	-1	0	0	0	0	-1	-1
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	5	0	0	1	-	1	7	1	0
Change in Cash	3	-1	-1	0	0	0	6	0	-1

Telomir Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	0	-13	-16	-10
Operating Cash Flow	0	-3	-5	-3
Investing Cash Flow	-	-	-	-
Financing Cash Flow	0	3	6	9
Change in Cash	0	0	1	6

Global Institutional Holdings in Telomir Pharmaceuticals Inc.

Funds	Holdings
KESTRA PRIVATE WEALTH SERVICES, LLC	0.02%
Vanguard Fiduciary Trust Co	0.2%
Northern Trust Corp	0.06%
UBS Group AG	0.01%
Praetorian Wealth Management Inc	0.03%

See all

Insights on Telomir Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 40.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, TELO stock has moved down by -3.1%

About Telomir Pharmaceuticals Inc.

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson's disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer's disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. in October 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Miami, Florida.

Organisation	Telomir Pharmaceuticals Inc.
Headquarters	100 SE 2nd Street, Miami, FL, United States, 33131
Industry	Biotechnology
CEO	Mr. Erez Aminov
E-voting on shares	Click here to vote

Key Management of Telomir Pharmaceuticals Inc.

Name	Title
Mr. Erez Aminov	Chairman of the Board & CEO
Mr. Alan Weichselbaum CPA, M.B.A.	Chief Financial Officer
Dr. Itzchak Angel Ph.D.	Chief Scientific Advisor

FAQs

What is Telomir Pharmaceuticals Inc. share price today?

Telomir Pharmaceuticals Inc. share price today is $1.24 as on June 27, 2026 at 8:45 am IST at the close of the market. Telomir Pharmaceuticals Inc. share today touched a day high of $1.27 and a low of $1.21.

What is the 52 week high and 52 week low for Telomir Pharmaceuticals Inc. share?

Telomir Pharmaceuticals Inc. share touched a 52 week high of $3.1 on July 18, 2025 and a 52 week low of $1.05 on February 12, 2026. Telomir Pharmaceuticals Inc. stock price today i.e. June 27, 2026 at 8:45 am IST is closed at $1.24,which is 60.00% down from its 52 week high and 18.10% up from its 52 week low.

What is Telomir Pharmaceuticals Inc.'s market capitalisation today?

Telomir Pharmaceuticals Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:45 am IST.

How to invest in Telomir Pharmaceuticals Inc. Stock (TELO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Telomir Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Telomir Pharmaceuticals Inc. Shares that will get you 1.2097 shares as per Telomir Pharmaceuticals Inc. share price of $1.24 per share as on June 27, 2026 at 8:45 am IST.

What is the minimum amount required to buy Telomir Pharmaceuticals Inc. Stock (TELO) from India?

Indian investors can start investing in Telomir Pharmaceuticals Inc. (TELO) shares with as little as ₹94.3 or $1 (as of June 29, 2026 at 8:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Telomir Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on June 29, 2026 at 8:41 am IST). Based on Telomir Pharmaceuticals Inc. share’s latest price of $1.24 as on June 27, 2026 at 8:45 am IST, you will get 8.0645 shares of Telomir Pharmaceuticals Inc.. Learn more about fractional shares .